E-Mail
IMAGE: A research participant in the MS pilot study does exercise training in the Ekso NR at Kessler Foundation. view more
Credit: Kessler Foundation/Jody Banks
East Hanover, NJ. May 28, 2021. A team of multiple sclerosis (MS) experts at Kessler Foundation led the first pilot randomized controlled trial of robotic-exoskeleton assisted exercise rehabilitation (REAER) effects on mobility, cognition, and brain connectivity in people with substantial MS-related disability. Their results showed that REAER is likely an effective intervention, and is a promising therapy for improving the lives of those with MS.
The article, A pilot randomized controlled trial of robotic exoskeleton-assisted exercise rehabilitation in multiple sclerosis, (doi: 10.1016/j.msard.2021.102936) was published on April 4, 2021, by